DexCom Inc (DXCM)
Working capital turnover
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 4,033,000 | 3,954,000 | 3,934,800 | 3,801,800 | 3,622,300 | 3,403,000 | 3,197,600 | 3,022,500 | 2,909,800 | 2,792,800 | 2,673,400 | 2,572,300 | 2,448,500 | 2,319,200 | 2,169,900 | 2,026,600 | 1,926,700 | 1,820,600 | 1,716,000 | 1,600,600 |
Total current assets | US$ in thousands | 4,301,400 | 4,262,800 | 4,848,400 | 4,620,700 | 4,425,900 | 4,698,400 | 5,002,900 | 3,767,400 | 3,668,800 | 3,398,500 | 3,808,700 | 3,746,600 | 3,684,400 | 3,656,200 | 3,474,200 | 3,445,100 | 3,424,800 | 3,237,100 | 3,033,000 | 1,995,700 |
Total current liabilities | US$ in thousands | 2,932,000 | 1,734,500 | 1,722,200 | 1,594,200 | 1,556,000 | 1,678,600 | 2,069,700 | 1,865,000 | 1,839,300 | 900,500 | 807,000 | 711,400 | 720,800 | 734,900 | 600,700 | 604,100 | 614,100 | 506,400 | 400,100 | 342,800 |
Working capital turnover | 2.95 | 1.56 | 1.26 | 1.26 | 1.26 | 1.13 | 1.09 | 1.59 | 1.59 | 1.12 | 0.89 | 0.85 | 0.83 | 0.79 | 0.76 | 0.71 | 0.69 | 0.67 | 0.65 | 0.97 |
December 31, 2024 calculation
Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $4,033,000K ÷ ($4,301,400K – $2,932,000K)
= 2.95
The working capital turnover of DexCom Inc has exhibited a fluctuating trend over the reporting periods from March 31, 2020, to December 31, 2024. The metric started at 0.97 in March 2020 and experienced ups and downs before showing an increasing trend in recent periods. It reached a peak of 2.95 by December 31, 2024.
A higher working capital turnover ratio indicates that the company is efficiently managing its working capital to generate sales. In the case of DexCom Inc, the increasing trend suggests that the company has been able to improve its efficiency in utilizing its working capital to generate revenue over time.
However, it is important to note that a very high working capital turnover ratio could also indicate aggressive management of working capital, which may not always be sustainable in the long term. Monitoring this ratio along with other financial metrics can provide a more comprehensive view of the company's overall financial health and operational effectiveness.
Peer comparison
Dec 31, 2024